Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBF.9EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBF.9EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBF.9ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.9ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.4.5EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.1.4.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.1.4.5ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.1.4.5ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.1.4.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.1.4.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.1.4.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.4.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BE.1.4.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BE.1.4.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BE.1.4.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BE.1.4.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BE.1.4.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BE.1.4.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.4.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.6.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.6.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.6.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.6.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.6.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.6.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.6.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.6.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.47.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.47.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.47.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.47.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.47.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.47.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.47.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.47.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBF.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBF.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBF.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBF.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBF.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CF.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CF.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CF.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CF.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CF.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used